S.L. 437.64 Art. 8Authorisation of administration of hormonal products and Beta-agonists.

(1) Hormonal products and Beta-agonists which are authorised in accordance with rule 6 shall be in accordance with the requirements established in European Directives 81/851/EEC and

81/852/EEC.

(2) Without prejudice to sub-rule (1), the following are not authorised:

(a) the following hormonal products:

(i) products acting as a deposit;

(ii) products with a withdrawal period of more than fifteen days after the end of treatment;

(iii) products which:

(1) were authorised under rules that preceded the national legislation laying down procedures in conformity with international agreement for the authorisation and supervision of medicinal products for human and veterinary use;

(2) whose conditions of use are not known; or

(3) which no reagents or equipment exist for use in the analytical techniques for detecting the presence of residues in excess of the permitted limits; and

(b) veterinary medicinal products containing betaagonists which have a withdrawal period of more than twenty-eight days after the end of treatment.